Published in PLoS One on February 16, 2010
Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrob Agents Chemother (2011) 1.40
Genotypic-phenotypic discrepancies between antibiotic resistance characteristics of Escherichia coli isolates from calves in management settings with high and low antibiotic use. Appl Environ Microbiol (2011) 0.92
Plasmidome-analysis of ESBL-producing escherichia coli using conventional typing and high-throughput sequencing. PLoS One (2013) 0.88
Regional dissemination of a trimethoprim-resistance gene cassette via a successful transposable element. PLoS One (2012) 0.88
Crystal structures of Klebsiella pneumoniae dihydrofolate reductase bound to propargyl-linked antifolates reveal features for potency and selectivity. Antimicrob Agents Chemother (2014) 0.85
Crystal Structures of Trimethoprim-Resistant DfrA1 Rationalize Potent Inhibition by Propargyl-Linked Antifolates. ACS Infect Dis (2016) 0.82
A multiple antibiotic and serum resistant oligotrophic strain, Klebsiella pneumoniae MB45 having novel dfrA30, is sensitive to ZnO QDs. Ann Clin Microbiol Antimicrob (2011) 0.81
Breaking the Spell: Combating Multidrug Resistant 'Superbugs'. Front Microbiol (2016) 0.81
Bacterial clonal diagnostics as a tool for evidence-based empiric antibiotic selection. PLoS One (2017) 0.77
Structural Diversity of Class 1 Integrons in Multiresistant Strains of Escherichia coli Isolated from Patients in a Hospital in Mexico City. Curr Microbiol (2015) 0.76
Sulfonamide Resistance Genes (sul) M in Extended Spectrum Beta Lactamase (ESBL) and Non-ESBL Producing Escherichia coli Isolated From Iranian Hospitals. Jundishapur J Microbiol (2015) 0.75
Within-population distribution of trimethoprim resistance in Escherichia coli before and after a community-wide intervention on trimethoprim use. Antimicrob Agents Chemother (2014) 0.75
Antimicrobial resistance in commensal Escherichia coli from pigs during metaphylactic trimethoprim and sulfamethoxazole treatment and in the post-exposure period. Int J Environ Res Public Health (2015) 0.75
Prevalence, serotyping and antimicrobials resistance mechanism of Salmonella enterica isolated from clinical and environmental samples in Saudi Arabia. Braz J Microbiol (2017) 0.75
Antimicrobial resistance. Is a major threat to public health. BMJ (1998) 4.18
Integrons and gene cassettes in the enterobacteriaceae. Antimicrob Agents Chemother (2001) 3.45
Trimethoprim and sulfonamide resistance. Antimicrob Agents Chemother (1995) 3.19
Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob (2007) 3.07
Characterisation of two new gene cassettes, aadA5 and dfrA17. FEMS Microbiol Lett (2000) 2.30
Bacterial genome size reduction by experimental evolution. Proc Natl Acad Sci U S A (2005) 2.13
Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E. coli UTIs. Br J Gen Pract (2006) 1.97
Resistance to trimethoprim and sulfonamides. Vet Res (2001) 1.95
Plasmids spread very fast in heterogeneous bacterial communities. Genetics (2002) 1.55
Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother (2009) 1.51
The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada. J Antimicrob Chemother (2006) 1.40
Integrons and gene cassettes in clinical isolates of co-trimoxazole-resistant Gram-negative bacteria. Clin Microbiol Infect (2005) 1.39
Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. J Antimicrob Chemother (2006) 1.38
Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance. J Antimicrob Chemother (2002) 1.35
The prevalence of trimethoprim-resistance-conferring dihydrofolate reductase genes in urinary isolates of Escherichia coli in Korea. J Antimicrob Chemother (2001) 1.34
Transfer of antimicrobial resistance plasmids from Klebsiella pneumoniae to Escherichia coli in the mouse intestine. J Antimicrob Chemother (2008) 1.06
Analysis and distribution of class 1 and class 2 integrons and associated gene cassettes among Escherichia coli isolates from swine, horses, cats and dogs collected in the BfT-GermVet monitoring study. J Antimicrob Chemother (2008) 1.06
Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother (2003) 1.03
Prevalence of dfr genes associated with integrons and dissemination of dfrA17 among urinary isolates of Escherichia coli in Korea. J Antimicrob Chemother (2004) 1.03
Standard and real-time multiplex PCR methods for detection of trimethoprim resistance dfr genes in large collections of bacteria. Clin Microbiol Infect (2007) 0.89
Two new dfr genes in trimethoprim-resistant integron-negative Escherichia coli isolates. Antimicrob Agents Chemother (2007) 0.87
Analysis of parameters and validation of method for normalized interpretation of antimicrobial resistance. Int J Antimicrob Agents (2003) 0.84
Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother (2008) 2.88
Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet (2012) 2.35
Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother (2003) 1.89
Dissemination of Escherichia coli with CTX-M type ESBL between humans and yellow-legged gulls in the south of France. PLoS One (2009) 1.87
Dissemination of multidrug-resistant bacteria into the Arctic. Emerg Infect Dis (2008) 1.74
Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis. Bull World Health Organ (2012) 1.60
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis. J Antimicrob Chemother (2009) 1.52
Intrafamilial spread of highly virulent staphylococcus aureus strains carrying the gene for Panton-Valentine leukocidin. Scand J Infect Dis (2002) 1.46
[Time to abandon "the house wine". Stop for uncritical empiric use of cefuroxime]. Lakartidningen (2009) 1.43
The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada. J Antimicrob Chemother (2006) 1.40
Breakpoints for susceptibility testing should not divide wild-type distributions of important target species. Antimicrob Agents Chemother (2009) 1.39
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med (2015) 1.34
Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J Antimicrob Chemother (2007) 1.32
Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue. J Antimicrob Chemother (2008) 1.16
Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J Antimicrob Chemother (2008) 1.13
Integrons and multidrug resistance among Escherichia coli causing community-acquired urinary tract infection in southern India. APMIS (2004) 1.03
Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella spp. from Norway and Sweden. Diagn Microbiol Infect Dis (2010) 1.02
'Pre-emptive culturing' will improve the chance of 'getting it right' when empirical therapy of urinary tract infections fails. J Antimicrob Chemother (2009) 0.97
Acquired sulphonamide resistance genes in faecal Escherichia coli from healthy children in Bolivia and Peru. Int J Antimicrob Agents (2005) 0.94
Asymptomatic bacteriuria in a population of elderly in municipal institutional care. Scand J Prim Health Care (2002) 0.94
Sequence types and plasmid carriage of uropathogenic Escherichia coli devoid of phenotypically detectable resistance. J Antimicrob Chemother (2011) 0.94
Mannitol salt agar-cefoxitin combination as a screening medium for methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 0.91
Characterisation of blaTEM genes and types of β-lactamase plasmids in Neisseria gonorrhoeae - the prevalent and conserved blaTEM-135 has not recently evolved and existed in the Toronto plasmid from the origin. BMC Infect Dis (2014) 0.89
Setting interpretive breakpoints for antimicrobial susceptibility testing using disk diffusion. Int J Antimicrob Agents (2011) 0.89
High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread. J Antimicrob Chemother (2013) 0.89
Antibiotic stewardship: a call for action by the urologic community. Eur Urol (2013) 0.87
Biofilm formation by Staphylococcus aureus isolates from skin and soft tissue infections. Curr Microbiol (2015) 0.84
The detection and verification of carbapenemases using ertapenem and Matrix Assisted Laser Desorption Ionization-Time of Flight. BMC Microbiol (2014) 0.84
Antibiotic use and Escherichia coli resistance trends for quinolones and cotrimoxazole in Sweden. Scand J Infect Dis (2002) 0.83
Staphylococci in primary skin and soft tissue infections in a Swedish county. Scand J Infect Dis (2008) 0.83
Professional challenges and opportunities in clinical microbiology and infectious diseases in Europe. Lancet Infect Dis (2011) 0.81
Antibiotic resistance among Campylobacter jejuni/coli strains acquired in Sweden and abroad: a longitudinal study. Scand J Infect Dis (2003) 0.80
Effect of excluding duplicate isolates of Escherichia coli and Staphylococcus aureus in a 14 year consecutive database. J Antimicrob Chemother (2007) 0.77
Extended antimicrobial resistance screening of the dominant faecal Escherichia coli and of rare resistant clones. Int J Antimicrob Agents (2005) 0.77
[In Process Citation]. Lakartidningen (2015) 0.75
Developments in the recent past--hospital hygiene and antimicrobials. Medical Microbiology: a tool in control of health-care-associated infections. APMIS (2007) 0.75
[New guidelines for vancomycin in staphylococcal infections]. Lakartidningen (2010) 0.75
National dissemination of EUCAST guidelines is a shared responsibility. Clin Microbiol Infect (2020) 0.75
Searching High and Low: Call for a Joint European Society for Paediatric Infectious Diseases-European Committee on Antimicrobial Susceptibility Testing Survey on Dosage of Antibacterial Agents in Children-Part One. Pediatr Infect Dis J (2022) 0.75
Living with extended-spectrum β-lactamase: a qualitative study of patient experiences. Am J Infect Control (2013) 0.75